Coronavirus: Clinical Trials

2 trials for Coronavirus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 1, Unknown 1

Follow Coronavirus: new trials by email Literature Review of Coronavirus trials Research Report on Coronavirus

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
alpha one antitrypsin inhalation - Coronavirus
Early Phase 1UnknownMinistry of Health, Saudi Arabia1502020-06-012020-05-13
COVID-19 Convalescent Plasma
anti-SARS-CoV-2 convalescent plasma - Coronavirus
Early Phase 1CompletedUniversity of Chicago102020-04-102024-02-28

Narrower conditions

Coronavirus Infections (2)  ·  COVID-19 (1)

Broader conditions

Coronaviridae Infections (2)  ·  Infections (2)  ·  Nidovirales Infections (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Lung Diseases (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Sponsors

Ministry of Health, Saudi Arabia (1)  ·  University of Chicago (1)

Countries

Saudi Arabia (1)  ·  United States (1)

Top investigators

Maria Lucia Madariaga, MD (1)

Results publications

PMID 33044747, PMID 34013969, PMID 36734509, PMID 37162745